etravirine has been researched along with Acute Lymphoid Leukemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alongi, M; Angeli, L; Armand-Ugon, M; Baltzinger, M; Bec, G; Bellucci, L; Botta, M; Casaluce, G; Dumas, P; Ennifar, E; Esté, JA; Giorgi, G; Gonzalez, E; Maga, G; Radi, M; Samuele, A; Tafi, A; Zanoli, S | 1 |
Chen, FE; Chen, WX; De Clercq, E; He, QQ; Pannecouque, C; Piao, HR; Wu, HQ; Wu, Y; Yan, ZH | 1 |
Chen, F; De Clercq, E; Han, S; Pannecouque, C; Sang, Y; Zhuang, C | 1 |
3 other study(ies) available for etravirine and Acute Lymphoid Leukemia
Article | Year |
---|---|
Discovery of chiral cyclopropyl dihydro-alkylthio-benzyl-oxopyrimidine (S-DABO) derivatives as potent HIV-1 reverse transcriptase inhibitors with high activity against clinically relevant mutants.
Topics: Cell Line, Tumor; Computer Simulation; Drug Design; Drug Resistance, Viral; HIV Reverse Transcriptase; Humans; Kinetics; Models, Molecular; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidinones; Reverse Transcriptase Inhibitors; Stereoisomerism; Sulfides; Surface Plasmon Resonance | 2009 |
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Topics: Anti-HIV Agents; Benzamides; Cell Survival; Cells, Cultured; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Models, Molecular; Molecular Docking Simulation; Molecular Structure; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication | 2014 |
Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Apoptosis; Drug Design; Female; HIV Infections; HIV-1; Humans; Ligands; Male; Mice; Microsomes, Liver; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rats; Reverse Transcriptase Inhibitors; Tissue Distribution; Tumor Cells, Cultured; Virus Replication | 2019 |